Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of ramucirumab treatment for patients with hepatocellular carcinoma who progressed on sorafenib with α-fetoprotein concentrations of at least 400 ng/ml.
Zheng, Hanrui; Qin, Zhou; Qiu, Xingjian; Zhan, Mei; Wen, Feng; Xu, Ting.
Affiliation
  • Zheng H; Department of Clinical Pharmacy, West China Hospital, Sichuan University, Chengdu, China.
  • Qin Z; Department of Clinical Pharmacy, West China Hospital, Sichuan University, Chengdu, China.
  • Qiu X; Shishi High School, Chengdu, China.
  • Zhan M; Department of Clinical Pharmacy, West China Hospital, Sichuan University, Chengdu, China.
  • Wen F; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Xu T; West China Biomedical Big Data Center, Sichuan University, Chengdu, China.
J Med Econ ; 23(4): 347-352, 2020 Apr.
Article in En | MEDLINE | ID: mdl-31856618
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alpha-Fetoproteins / Carcinoma, Hepatocellular / Antibodies, Monoclonal, Humanized / Sorafenib / Antineoplastic Agents Type of study: Clinical_trials / Health_economic_evaluation Aspects: Patient_preference Limits: Humans Country/Region as subject: America do norte Language: En Journal: J Med Econ Journal subject: SERVICOS DE SAUDE Year: 2020 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alpha-Fetoproteins / Carcinoma, Hepatocellular / Antibodies, Monoclonal, Humanized / Sorafenib / Antineoplastic Agents Type of study: Clinical_trials / Health_economic_evaluation Aspects: Patient_preference Limits: Humans Country/Region as subject: America do norte Language: En Journal: J Med Econ Journal subject: SERVICOS DE SAUDE Year: 2020 Document type: Article Affiliation country: China